$abvc

PDS Biotechnology's stock is experiencing a significant surge following the announcement of an extended global patent for its PDS0101 drug. This development, coupled with ongoing Phase [--] trials, is driving strong positive sentiment among investors and social media.

About $abvc

PDS Biotechnology is a clinical-stage biopharmaceutical company focused on developing targeted cancer immunotherapies.

Engagements: [--] (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [-----]
[--] Month: [-----] +2.70%
[--] Months: [-------] -94%
[--] Year: [---------] -20%
1-Year High: [-------] on 2025-07-03
1-Year Low: [--] on 2025-12-13

Engagements by network (24h): X: [---] TikTok: [--]

Mentions: [--] (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
1-Year High: [------] on 2025-07-03
1-Year Low: [--] on 2025-11-01

Mentions by network (24h): X: [--] TikTok: [--]

Creators: [--] (24h)

Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $abvc in the last [--] hours which is down 9.10% from [--] in the previous [--] hours Daily Average: [---]
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-11-01

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing